Human CD6 Down-Modulation following T-Cell Activation Compromises Lymphocyte Survival and Proliferative Responses

Abstract

Available evidence indicates that the CD6 lymphocyte surface receptor is involved in T-cell developmental and activation processes, by facilitating cell-to-cell adhesive contacts with antigen-presenting cells and likely modulating T-cell receptor (TCR) signaling. Here, we show that in vitro activation of human T cells under different TCR-ligation conditions leads to surface downregulation of CD6 expression. This phenomenon was (i) concomitant to increased levels of soluble CD6 (sCD6) in culture supernatants, (ii) partially reverted by protease inhibitors, (iii) not associated to CD6 mRNA down-regulation, and (iv) reversible by stimulus removal. CD6 down-modulation inversely correlated with the upregulation of CD25 in both FoxP3− (Tact) and FoxP3+ (Treg) T-cell subsets. Furthermore, ex vivo analysis of peripheral CD4+ and CD8+ T cells with activated (CD25+) or effector memory (effector memory T cell, CD45RA−CCR7−) phenotype present lower CD6 levels than their naïve or central memory (central memory T cell, CD45RA−CCR7+) counterparts. CD6lo/− T cells resulting from in vitro T-cell activation show higher apoptosis and lower proliferation levels than CD6hi T cells, supporting the relevance of CD6 in the induction of proper T-cell proliferative responses and resistance to apoptosis. Accordingly, CD6 transfectants also showed higher viability when exposed to TCR-independent apoptosis-inducing conditions in comparison with untransfected cells. Taken together, these results provide insight into the origin of sCD6 and the previously reported circulating CD6-negative T-cell subset in humans, as well as into the functional consequences of CD6 down-modulation on ongoing T-cell responses, which includes sensitization to apoptotic events and attenuation of T-cell proliferative responses.

Phenotypic and functional characterization of the CD6-ALCAM T-cell co-stimulatory pathway after allogeneic cell transplantation

“…CD6 expression also varies as T cells undergo maturation. 31 Naïve and central memory T cells express high levels of CD6 compared to more mature effector memory T cells.…”

Silica Induction of Diverse Inflammatory Proteome in Lungs of Lupus-Prone Mice Quelled by Dietary Docosahexaenoic Acid Supplementation

“…CD6, a lymphocyte surface receptor that associates with the T cell receptor/CD3 complex, acts as a co-stimulatory molecule for T cell activation (74). sCD6 is detectable in patients with systemic autoimmune and inflammatory disorders (75,76). Other TNF receptor superfamily proteins that were upregulated by cSiO 2 , downregulated by DHA, and have pertinence to lupus and autoimmunity include sBAFFR (77), sTNFR1 and sTNFR2 (43), and sTRAIL (78)(79)(80).…”

Genetically predicted levels of the human plasma proteome and risk of stroke: a Mendelian Randomization study

“…In addition, we have identi ed CD6, a lymphocyte surface receptor, associated with increased risk of any stroke. CD6 is a pan T cell marker 66,67 , and involved in T cell proliferation and activation through its interaction with ALCAM (activated leukocyte cell adhesion molecule) 68 . The interaction of CD6 and ALCAM is required to promote an in ammatory T cell response 69 .…”